Literature DB >> 32588924

Venetoclax Boosts Benefits of R-EPOCH in Aggressive B-Cell Lymphomas.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32588924      PMCID： PMC7330919          DOI： 10.1634/theoncologist.2020-0569

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  1 in total

1.  [Clonal-related transformation from Waldenström macroglobulinemia to diffuse large B cell lymphoma during the treatment of ibrutinib: a case report and literature review].

Authors:  Y Xia; H Y Zhu; L Wang; R Z Chen; W Chen; C Y Ding; W Xu; J Y Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.